Semaglutide and tirzepatide products are under scrutiny after South Africa’s health regulators warned against the use, prescription and dispensing of recalled iDEXIS medicines. The South African...
Clicks is charging ahead with one of its biggest growth drives yet, after posting another strong year of earnings and confirming plans to open hundreds of...